Tobramycin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76204-029 -
Package NDC
76204-029-56 -
Application number
ANDA201422 -
SPL ID
459f9e6a-cdbc-32cb-e063-6294a90a03e3 -
SPL set ID
e8205898-0162-4e6c-bcf1-87cb074ab9ae -
UNII
VZ8RRZ51VK -
RxCUI
348719
What the source publishes
- Labeler
- Ritedose Pharmaceuticals, LLC
- Active ingredients
- Tobramycin
- Form
- SOLUTION
- Routes
- RESPIRATORY (INHALATION)
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Tobramycin",
"splId": "459f9e6a-cdbc-32cb-e063-6294a90a03e3",
"labels": [
{
"setId": "e8205898-0162-4e6c-bcf1-87cb074ab9ae",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8205898-0162-4e6c-bcf1-87cb074ab9ae",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e8205898-0162-4e6c-bcf1-87cb074ab9ae"
}
],
"routes": [
"RESPIRATORY (INHALATION)"
],
"labeler": "Ritedose Pharmaceuticals, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "14 POUCH in 1 CARTON (76204-029-56) / 4 AMPULE in 1 POUCH / 5 mL in 1 AMPULE",
"package_ndc": "76204-029-56",
"identifierStatus": "well-formed",
"marketing_start_date": "20250325"
}
],
"productId": "76204-029_459f9e6a-cdbc-32cb-e063-6294a90a03e3",
"useDomain": "unknown",
"dosageForm": "SOLUTION",
"productNdc": "76204-029",
"deaSchedule": null,
"genericName": "Tobramycin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TOBRAMYCIN",
"strength": "300 mg/5mL"
}
],
"applicationNumber": "ANDA201422",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250325",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175477",
"M0000946"
],
"unii": [
"VZ8RRZ51VK"
],
"rxcui": [
"348719"
],
"spl_set_id": [
"e8205898-0162-4e6c-bcf1-87cb074ab9ae"
],
"pharm_class_cs": [
"Aminoglycosides [CS]"
],
"pharm_class_epc": [
"Aminoglycoside Antibacterial [EPC]"
],
"manufacturer_name": [
"Ritedose Pharmaceuticals, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76204-029_459f9e6a-cdbc-32cb-e063-6294a90a03e3"